Not applicableStudy completedNCT00572793
What this trial is testing
Evaluate the Use of Placenta Protein 13 (PP13) in the First Trimester of Pregnancy as a Diagnostic Aiding Tool in the Assessment of the Risk for Developing Preeclampsia in Women With Low and Unknown Risk
Who this might be right for
Preeclampsia
Carl Weiner, MD 431